Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Dec;76(6):2446–2450. doi: 10.1172/JCI112261

Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.

C von Schacky, P C Weber
PMCID: PMC424407  PMID: 3001149

Abstract

Metabolism and effects on platelet function of 6 g/d for 6 d of either eicosapentaenoic acid (EPA, C20:5 omega-3) or docosahexaenoic acid (DCHA, C22:6 omega-3) in volunteers were compared in a randomized crossover study. Incorporation kinetics revealed that EPA appeared in plasma free fatty acids and plasma phospholipids after 4 h, but was not incorporated into platelet phosphatidylcholine and -ethanolamine until day 6. This indicates that platelet fatty acid composition does not immediately reflect that of the surrounding plasma milieu, but rather may be determined during megakaryocyte maturation. Importantly, EPA was not incorporated into platelet phosphatidylinositol or -serine in vivo, thus reflecting selective biosynthesis of platelet phospholipids. After dietary EPA, C22:5 omega-3 increased in plasma and platelet phospholipids. In contrast, DCHA-levels were unaltered. After DCHA-ingestion, C20:5 omega-3 concentrations rose in plasma phospholipids, implying that retroconversion took place. These findings indicate that dietary DCHA can serve as a source of EPA. During this short-term study, ingestion of both EPA and DCHA resulted in reduced platelet aggregation in response to collagen. The response to ADP was lowered significantly only by DCHA. After either EPA or DCHA, thromboxane formation was unchanged in serum derived from clotted whole blood as was total in vivo synthesis measured by excretion of immunoreactive 2,3-dinor thromboxane B2/3. We conclude that DCHA reduces platelet responsiveness, contributing to the antithrombotic effects of omega-3 fatty acid-rich fish oil ingestion, of which DCHA is a major component.

Full text

PDF
2446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, INSULL W., Jr, HIRSCH J., STOFFEL W., PETERSON M. L., FARQUHAR J. W., MILLER T., THOMASSON H. J. The effect on human serum-lipids of a dietary fat, highly unsaturated, but poor in essential fatty acids. Lancet. 1959 Jan 17;1(7064):115–119. doi: 10.1016/s0140-6736(59)90002-9. [DOI] [PubMed] [Google Scholar]
  2. Ahmed A. A., Holub B. J. Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil. Lipids. 1984 Aug;19(8):617–624. doi: 10.1007/BF02534720. [DOI] [PubMed] [Google Scholar]
  3. Aveldaño M. I., Sprecher H. Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. J Biol Chem. 1983 Aug 10;258(15):9339–9343. [PubMed] [Google Scholar]
  4. Careaga M. M., Sprecher H. Synthesis of two hydroxy fatty acids from 7,10,13,16,19-docosapentaenoic acid by human platelets. J Biol Chem. 1984 Dec 10;259(23):14413–14417. [PubMed] [Google Scholar]
  5. Dyerberg J., Bang H. O., Stoffersen E., Moncada S., Vane J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978 Jul 15;2(8081):117–119. doi: 10.1016/s0140-6736(78)91505-2. [DOI] [PubMed] [Google Scholar]
  6. Fischer S., Weber P. C. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature. 1984 Jan 12;307(5947):165–168. doi: 10.1038/307165a0. [DOI] [PubMed] [Google Scholar]
  7. Fischer S., von Schacky C., Siess W., Strasser T., Weber P. C. Uptake, release and metabolism of docosahexaenoic acid (DHA, c22:6 omega 3) in human platelets and neutrophils. Biochem Biophys Res Commun. 1984 May 16;120(3):907–918. doi: 10.1016/s0006-291x(84)80193-x. [DOI] [PubMed] [Google Scholar]
  8. Galloway J. H., Cartwright I. J., Woodcock B. E., Greaves M., Russell R. G., Preston F. E. Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools. Clin Sci (Lond) 1985 Apr;68(4):449–454. doi: 10.1042/cs0680449. [DOI] [PubMed] [Google Scholar]
  9. Goodnight S. H., Jr, Harris W. S., Connor W. E., Illingworth D. R. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis. 1982 Mar-Apr;2(2):87–113. doi: 10.1161/01.atv.2.2.87. [DOI] [PubMed] [Google Scholar]
  10. Kobatake Y., Kuroda K., Jinnouchi H., Nishide E., Innami S. Differential effects of dietary eicosapentaenoic and docosahexaenoic fatty acids on lowering of triglyceride and cholesterol levels in the serum of rats on hypercholesterolemic diet. J Nutr Sci Vitaminol (Tokyo) 1984 Aug;30(4):357–372. doi: 10.3177/jnsv.30.357. [DOI] [PubMed] [Google Scholar]
  11. Kremer J. M., Bigauoette J., Michalek A. V., Timchalk M. A., Lininger L., Rynes R. I., Huyck C., Zieminski J., Bartholomew L. E. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet. 1985 Jan 26;1(8422):184–187. doi: 10.1016/s0140-6736(85)92024-0. [DOI] [PubMed] [Google Scholar]
  12. Kromhout D., Bosschieter E. B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985 May 9;312(19):1205–1209. doi: 10.1056/NEJM198505093121901. [DOI] [PubMed] [Google Scholar]
  13. Lee T. H., Hoover R. L., Williams J. D., Sperling R. I., Ravalese J., 3rd, Spur B. W., Robinson D. R., Corey E. J., Lewis R. A., Austen K. F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985 May 9;312(19):1217–1224. doi: 10.1056/NEJM198505093121903. [DOI] [PubMed] [Google Scholar]
  14. Lee T. H., Mencia-Huerta J. M., Shih C., Corey E. J., Lewis R. A., Austen K. F. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest. 1984 Dec;74(6):1922–1933. doi: 10.1172/JCI111612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lorenz R., Spengler U., Fischer S., Duhm J., Weber P. C. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation. 1983 Mar;67(3):504–511. doi: 10.1161/01.cir.67.3.504. [DOI] [PubMed] [Google Scholar]
  16. Needleman P., Raz A., Minkes M. S., Ferrendelli J. A., Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A. 1979 Feb;76(2):944–948. doi: 10.1073/pnas.76.2.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Phillipson B. E., Rothrock D. W., Connor W. E., Harris W. S., Illingworth D. R. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985 May 9;312(19):1210–1216. doi: 10.1056/NEJM198505093121902. [DOI] [PubMed] [Google Scholar]
  18. Rao G. H., Radha E., White J. G. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun. 1983 Dec 16;117(2):549–555. doi: 10.1016/0006-291x(83)91235-4. [DOI] [PubMed] [Google Scholar]
  19. Schlenk H., Sand D. M., Gellerman J. L. Retroconversion of docosahexaenoic acid in the rat. Biochim Biophys Acta. 1969;187(2):201–207. doi: 10.1016/0005-2760(69)90028-9. [DOI] [PubMed] [Google Scholar]
  20. Siess W., Roth P., Scherer B., Kurzmann I., Böhlig B., Weber P. C. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet. 1980 Mar 1;1(8166):441–444. doi: 10.1016/s0140-6736(80)90995-2. [DOI] [PubMed] [Google Scholar]
  21. Stoffel W., Eker, Assad H., Sprecher H. Enzymatic studies on the mechanism of the retroconversion of C22-polyenoic fatty acids to their C20-homologues. Hoppe Seylers Z Physiol Chem. 1970 Dec;351(12):1545–1554. doi: 10.1515/bchm2.1970.351.2.1545. [DOI] [PubMed] [Google Scholar]
  22. Strasser T., Fischer S., Weber P. C. Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1540–1543. doi: 10.1073/pnas.82.5.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Terano T., Hirai A., Hamazaki T., Kobayashi S., Fujita T., Tamura Y., Kumagai A. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis. 1983 Mar;46(3):321–331. doi: 10.1016/0021-9150(83)90181-8. [DOI] [PubMed] [Google Scholar]
  24. WORNE H. E., SMITH L. W. Effects of certain pure long chain polyunsaturated fatty acid esters on the blood lipids of man; preliminary studies on the use of polyunsaturated fatty acid in atherosclerosis. Am J Med Sci. 1959 Jun;237(6):710–721. doi: 10.1097/00000441-195906000-00004. [DOI] [PubMed] [Google Scholar]
  25. Weiner T. W., Sprecher H. 22-Carbon polyenoic acids. Incorporation into platelet phospholipids and the synthesis of these acids from 20-carbon polyenoic acid precursors by intact platelets. J Biol Chem. 1985 May 25;260(10):6032–6038. [PubMed] [Google Scholar]
  26. Yorek M. A., Bohnker R. R., Dudley D. T., Spector A. A. Comparative utilization of n-3 polyunsaturated fatty acids by cultured human Y-79 retinoblastoma cells. Biochim Biophys Acta. 1984 Sep 12;795(2):277–285. doi: 10.1016/0005-2760(84)90076-6. [DOI] [PubMed] [Google Scholar]
  27. von Schacky C., Fischer S., Weber P. C. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985 Oct;76(4):1626–1631. doi: 10.1172/JCI112147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. von Schacky C., Siess W., Fischer S., Weber P. C. A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res. 1985 Apr;26(4):457–464. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES